These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9163685)
41. Dehydroepiandrosterone and two structural analogs inhibit 12-O-tetradecanoylphorbol-13-acetate stimulation of prostaglandin E2 content in mouse skin. Hastings LA; Pashko LL; Lewbart ML; Schwartz AG Carcinogenesis; 1988 Jun; 9(6):1099-102. PubMed ID: 2967126 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of proteinuria development in aging Sprague-Dawley rats and C57BL/6 mice by long-term treatment with dehydroepiandrosterone. Pashko LL; Fairman DK; Schwartz AG J Gerontol; 1986 Jul; 41(4):433-8. PubMed ID: 2941474 [TBL] [Abstract][Full Text] [Related]
43. Dietary intervention at middle age: caloric restriction but not dehydroepiandrosterone sulfate increases lifespan and lifetime cancer incidence in mice. Pugh TD; Oberley TD; Weindruch R Cancer Res; 1999 Apr; 59(7):1642-8. PubMed ID: 10197641 [TBL] [Abstract][Full Text] [Related]
44. Modulation of methylnitrosourea-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: dose-dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations. Lubet RA; Gordon GB; Prough RA; Lei XD; You M; Wang Y; Grubbs CJ; Steele VE; Kelloff GJ; Thomas CF; Moon RD Cancer Res; 1998 Mar; 58(5):921-6. PubMed ID: 9500451 [TBL] [Abstract][Full Text] [Related]
45. Antiobesity effects of dehydroepiandrosterone are mediated by futile substrate cycling in hepatocytes of BHE/cdb rats. McIntosh MK; Berdanier CD J Nutr; 1991 Dec; 121(12):2037-43. PubMed ID: 1834818 [TBL] [Abstract][Full Text] [Related]
46. Dehydroepiandrosterone Supplementation Combined with Whole-Body Vibration Training Affects Testosterone Level and Body Composition in Mice. Chen WC; Chen YM; Huang CC; Tzeng YD Int J Med Sci; 2016; 13(10):730-740. PubMed ID: 27766021 [TBL] [Abstract][Full Text] [Related]
47. Effects of dehydroepiandrosterone acetate on metabolism, body weight and composition of male and female rats. Tagliaferro AR; Davis JR; Truchon S; Van Hamont N J Nutr; 1986 Oct; 116(10):1977-83. PubMed ID: 2945908 [TBL] [Abstract][Full Text] [Related]
48. Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. Feo F; Daino L; Seddaiu MA; Simile MM; Pascale R; McKeating JA; Davliakos GP; Sudol KS; Melhem MF; Rao KN Carcinogenesis; 1991 Sep; 12(9):1581-6. PubMed ID: 1680032 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of tumor development by dehydroepiandrosterone and related steroids. Schwartz AG; Pashko L; Whitcomb JM Toxicol Pathol; 1986; 14(3):357-62. PubMed ID: 3024302 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of DNA synthesis in mouse epidermis and breast epithelium by dehydroepiandrosterone and related steroids. Pashko LL; Schwartz AG; Abou-Gharbia M; Swern D Carcinogenesis; 1981; 2(8):717-21. PubMed ID: 6456847 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one. Ciolino HP; MacDonald CJ; Yeh GC Cancer Res; 2002 Jul; 62(13):3685-90. PubMed ID: 12097275 [TBL] [Abstract][Full Text] [Related]
52. Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Hursting SD; Perkins SN; Phang JM Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7036-40. PubMed ID: 8041741 [TBL] [Abstract][Full Text] [Related]
53. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121 [TBL] [Abstract][Full Text] [Related]
54. Modifying influence of dehydroepiandrosterone on the development of dihydroxy-di-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats. Moore MA; Thamavit W; Tsuda H; Sato K; Ichihara A; Ito N Carcinogenesis; 1986 Feb; 7(2):311-6. PubMed ID: 2868807 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneoplastic liver nodules. Pascale RM; Simile MM; De Miglio MR; Nufris A; Seddaiu MA; Muroni MR; Danni O; Rao KN; Feo F Carcinogenesis; 1995 Jul; 16(7):1537-42. PubMed ID: 7614686 [TBL] [Abstract][Full Text] [Related]
56. Dehydroepiandrosterone decreases serum tumor necrosis factor-alpha and restores insulin sensitivity: independent effect from secondary weight reduction in genetically obese Zucker fatty rats. Kimura M; Tanaka S; Yamada Y; Kiuchi Y; Yamakawa T; Sekihara H Endocrinology; 1998 Jul; 139(7):3249-53. PubMed ID: 9645700 [TBL] [Abstract][Full Text] [Related]
57. Chemoprevention by dehydroepiandrosterone and indomethacin in a rat multiorgan carcinogenesis model. Shibata M; Hasegawa R; Imaida K; Hagiwara A; Ogawa K; Hirose M; Ito N; Shirai T Cancer Res; 1995 Nov; 55(21):4870-4. PubMed ID: 7585522 [TBL] [Abstract][Full Text] [Related]
58. Investigation into the effect of DHEA on renal carcinogenesis induced in the rat by a single dose of DMN. Ogiu T; Hard GC; Schwartz AG; Magee PN Nutr Cancer; 1990; 14(1):57-67. PubMed ID: 2142277 [TBL] [Abstract][Full Text] [Related]
59. Computer-aided structure analysis of an epimerized dehydroepiandrosterone derivative and its biological effect in a model of reactive gliosis. Hoyk Z; Csákvári E; Szájli A; Kóti J; Paragi G; Gyenes A; Wölfling J; Pfoh R; Rühl S; Párducz A Steroids; 2010 Mar; 75(3):265-71. PubMed ID: 20064537 [TBL] [Abstract][Full Text] [Related]
60. Dehydroepiandrosterone causes hyperplasia and impairs regeneration in rat liver. Kopplow K; Wayss K; Enzmann H; Mayer D Int J Oncol; 2005 Dec; 27(6):1551-8. PubMed ID: 16273211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]